Artelo Biosciences (ARTL)
(Delayed Data from NSDQ)
$1.34 USD
0.00 (-0.13%)
Updated Apr 25, 2024 12:36 PM ET
After-Market: $1.31 -0.03 (-2.24%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -1.05 |
EPS Last Quarter | -0.99 |
Last EPS Surprise | -241.38% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.07 |
Next Year | -1.59 |
EPS (TTM) | -3.14 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.05 | -0.74 | -2.07 | -1.59 |
# of Estimates | 1 | 1 | 2 | 1 |
Most Recent Consensus | -1.05 | -0.74 | -2.55 | -1.59 |
High Estimate | -1.05 | -0.74 | -1.59 | -1.59 |
Low Estimate | -1.05 | -0.74 | -2.55 | -1.59 |
Year ago EPS | -0.76 | -0.56 | -3.14 | -2.07 |
Year over Year Growth Est. | -38.16% | -32.14% | 34.08% | 23.19% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 2 | 0 |
Down Last 60 Days | 0 | 0 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.05 | -0.74 | -2.07 | -1.59 |
7 Days Ago | -1.05 | -0.74 | -2.07 | -1.59 |
30 Days Ago | NA | NA | -0.88 | NA |
60 Days Ago | NA | NA | -0.88 | NA |
90 Days Ago | NA | NA | -0.88 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.05 | -0.74 | -2.07 | -1.59 |
Zacks Consensus Estimate | -1.05 | -0.74 | -2.07 | -1.59 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.99 | -0.83 | -0.56 | -0.76 | NA |
Estimate | -0.29 | -0.70 | -0.93 | -0.99 | NA |
Difference | -0.70 | -0.13 | 0.37 | 0.23 | -0.06 |
Surprise | -241.38% | -18.57% | 39.78% | 23.23% | -49.24% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more